So hi, everyone. Welcome to today's webinar with PPMD, where we're joined by Capricor Therapeutics, who are providing a community update on their Phase 3 trial, HOPE-3, which was evaluating their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback